Drug interactions
The combination of d4T (stavudine, Zerit) with AZT (zidovudine, Retrovir) is antagonistic, with each drug reducing the two drugs’ combined anti-HIV effects[1]. Consequently, this combination is not recommended.
Taking the hepatitis C treatment ribavirin (Copegus / Rebetol / Virazole) when also taking d4T may increase the risk of a set of side-effects associated with elevated lactate including the rare, life-threatening condition lactic acidosis[2]. It may also increase the risk of body fat loss[3]. Test-tube studies also suggest that ribavirin and doxorubicin (Caelyx / Myocet) may block the production of the active form of d4T in the body, reducing the drug’s anti-HIV effects.
Caution should be used when d4T is taken with other drugs that may cause peripheral neuropathy. These include:
- Chloramphenicol (Kemicetine).
- Cisplatin (Platinex)
- Dapsone.
- ddC (zalcitabine, Hivid).
- ddI (didanosine, Videx / VidexEC).
- Ethambutol.
- Ethionamide.
- Hydralazine (Aprelosine).
- Isoniazid.
- Lithium (Camcolit / Liskonum / Priadel).
- Metronidazole (Flagyl / Flagyl S / Metrolyl).
- Nitrofurantoin (Furadantin / Macrobid / Macrodantin).
- Phenytoin (Epanutin).
- Vincristine (Oncovin).
latest aidsmap news
- Case report - viral load undetectable in blood, but detectable in semen
- 'Hidden epidemic' of HIV amongst African migrants in the United States
- Blood viral load predicts HIV transmission better than semen viral load in small study among MSM
- Infectiousness and antiretroviral therapy: reports look set to further fuel the debate
- Albendazole treatment of helminth co-infection in Kenyan HIV patients raises CD4 counts
- Justice Edwin Cameron calls for a campaign against 'misguided criminal laws and prosecutions'
- HIV prevalence and incidence in Uganda on the way up
- Half of Russian XDR-TB patients cured with aggressive treatment
- Updated British HIV pregnancy guidelines published
- Incidence increasing of HIV-associated multicentric Castleman's disease, a relatively rare lymphatic cancer
